Mouse spontaneous mammary adenocarcinoma as a suitable model of breast cancer in Iran
Abstract
Background: Breast cancer is a complicated disease and has various clinical manifestations and prognosis. The aim of this study is to make a breast cancer model suitable for basic, preclinical and clinical studies.Materials and methods: Five virgin Bulb/c mice aged 6 weeks and spontaneous Murine Mammary Adenocarcinoma Cells (MMAC) were used. After anesthesia induction, 1-3 million of MMACs were subcutaneously injected into the mice’s right flank. Four weeks after the tumor induction, tumor size in both length and width were weekly measured using caliper for 4 weeks. Histopathology studies were done 2 months later by Scraff- Boom-Richardson grading.Results: Visible tumors were appeared after 4 weeks. Take-rate of all cells was nearly 100%. Tumor sizes reached 0.6±0.1 mm3, 1.1±0.3, 1.68±0.5 and 3±0.7 cm3 with at fifth, sixth, seventh and eighth weeks respectively. The histopathological studies using H & E method showed invasive ductal carcinoma, grade II/III.Conclusions: Elucidation of the molecular mechanisms of breast cancer progression and metastasis has extremely gained from mouse models in which some stages of tumor progression are recapitulated.Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108.
Wilson CM, Tobin S, Young RC. The exploding worldwide cancer burden: the impact of cancer on women. Int J Gynecol Cancer. 2004 Jan-Feb;14(1):1-11.
Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al. Breast cancer in Iran: an epidemiological review. Breast J. 2007 Jul-Aug;13(4):383-91.
de Bock GH, Jacobi CE, Seynaeve C, Krol-Warmerdam EM, Blom J, van Asperen CJ, et al. A family history of breast cancer will not predict female early onset breast cancer in a population-based setting. BMC Cancer. 2008;8:203.
Simian M, Manzur T, Rodriguez V, de Kier Joffe EB, Klein S. A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice. Breast Cancer Res Treat. 2009 Jan;113(1):1-8.
Amat S, Penault-Llorca F, Cure H, Le Bouedec G, Achard JL, Van Praagh I, et al. Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy. Int J Oncol. 2002 Apr;20(4):791-6.
Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 1996 Nov 29;87(5):803-9.
Chulada PC, Thompson MB, Mahler JF, Doyle CM, Gaul BW, Lee C, et al. Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res. 2000 Sep 1;60(17):4705-8.
Files | ||
Issue | Vol 3 No 3&4 (2011) | |
Section | Original Articles | |
Keywords | ||
Mice adenocarcinoma model breast cancer |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |